Description |
phosphatidylinositol transfer protein membrane associated 2 |
copine 4 |
Image |
No pdb structure |
No pdb structure |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
- anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028)
- Asthma ( 32296059)
- Asthma (childhood onset) ( 30929738)
- Autism spectrum disorder or schizophrenia ( 28540026)
- Body fat distribution (leg fat ratio) ( 30664634)
- Body fat distribution (trunk fat ratio) ( 30664634)
- Brain morphology (MOSTest) ( 32665545)
- Educational attainment ( 25201988)
- Eosinophil percentage of white cells ( 32888494)
- High light scatter reticulocyte count ( 32888494)
- High light scatter reticulocyte percentage of red cells ( 32888494)
- Hip circumference adjusted for BMI ( 25673412)
- Household income (MTAG) ( 31844048)
- Intelligence (MTAG) ( 29326435)
- Macular thickness ( 30535121)
- Mean platelet volume ( 27863252)
- Menopause (age at onset) ( 26414677)
- Multiple sclerosis ( 31604244 24076602)
- Platelet count ( 21507922)
- Reticulocyte count ( 32888494)
- Reticulocyte fraction of red cells ( 32888494)
- Schizophrenia ( 28991256 25056061 29483656 23974872)
- Tourette syndrome ( 30818990)
- Type 2 diabetes ( 30054458)
- Uterine fibroids ( 31649266)
|
- Adult body size ( 32376654)
- Aggressiveness in attention deficit hyperactivity disorder ( 27021288)
- Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL) ( 28090653)
- Amyotrophic lateral sclerosis ( 22959728)
- Amyotrophic lateral sclerosis in C9orf72 mutation positive individuals ( 22959728)
- Body mass index ( 31453325 28892062 25673413)
- Body mass index variance ( 31453325)
- Body size at age 10 ( 32376654)
- Circulating leptin levels in high cardiovascular risk ( 31766143)
- Coronary artery aneurysm in Kawasaki disease ( 27171184)
- HDL cholesterol levels ( 32203549)
- Intracranial aneurysm ( 29531279)
- Iron status biomarkers (total iron binding capacity) ( 28334935)
- Metabolic syndrome ( 31589552)
- Motion sickness ( 25628336)
- Neutrophil count ( 21507922)
|
Interacting Genes |
3 interacting genes:
CPNE1
CPNE4
PTK2B
|
17 interacting genes:
ACTB
BCOR
BICD1
CCDC22
CEP162
CPNE1
MAP2K1
MYCBP
NECAB1
PDCD6
PITPNM2
PPP5C
RDX
SKIL
SPTBN1
UBE2M
UBE2O
|
Entrez ID |
57605 |
131034 |
HPRD ID |
08335 |
05017 |
Ensembl ID |
ENSG00000090975
|
ENSG00000196353
|
Uniprot IDs |
Q9BZ72
Q9UF51
|
B7Z370
Q4G168
Q96A23
|
PDB IDs |
|
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|